Radiosight develops ultra-wide imaging technology to aid in the diagnosis of skin cancer and to guide surgical decisions.
Radiosight develops ultra-wide imaging technology to aid in the diagnosis of skin cancer and to guide surgical decisions. The company was founded in 2020 and is headquartered in Hoboken, New Jersey.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2021 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |